Dual-Outflow Surgery for Glaucoma

Recent advances in biointerventional technology allow surgeons to enhance natural drainage pathways.

By: Steven R. Sarkisian, Jr., MD, Arkadiy Yadgarov, MD

Ophthalmology Management October 1, 2025 Vol 29, Issue October 2025 Page(s): 30-31

Clinical Report: Dual-Outflow Surgery for Glaucoma

Overview

Recent advancements in biointerventional technology have enabled the enhancement of both trabecular and uveoscleral drainage pathways in glaucoma surgery. This dual-outflow approach aims to improve patient outcomes by reducing medication dependency and preserving vision through early surgical intervention.

Background

The management of glaucoma has evolved significantly with the introduction of minimally invasive glaucoma surgery (MIGS) since 2012. This shift towards interventional glaucoma emphasizes early surgical intervention to alter disease progression and improve patient quality of life. Despite advancements, access to the uveoscleral pathway for surgical enhancement has been limited until now, highlighting the importance of recent technological developments.

Data Highlights

No numerical data available in the source material.

Key Findings

Rephrase findings for clarity and ensure they are directly supported by the source.

Clinical Implications

Surgeons can now offer a dual-outflow approach to glaucoma management, enhancing both natural drainage pathways to improve patient outcomes. This strategy not only reduces the burden of medication but also aligns with evolving guidelines advocating for individualized, stepwise surgical interventions.

Conclusion

The introduction of dual-outflow surgery represents a significant advancement in glaucoma treatment, enabling comprehensive management strategies that enhance patient care and preserve vision. Continued integration of these techniques into clinical practice is essential for optimizing outcomes.

PentaVision

Ophthalmology Management